bet9 Medpro (Pty) Ltd. Partners with Serum Institute India (SII) to Provide Vaccines in South Africa

bet9 to acquire 100% of generic businesses in US for $550M

bet9 appoints Umang Vohra and Prabir Jha to its management team

bet9 announces Q1 FY1516 Unaudited Consolidated Financial Results

bet9 announces a new respiratory inhaler: Synchrobreathe (SB), a state-of-the-art breath-actuated inhaler which will bring relief to millions of patients with Obstructive Airway Disease (OAD, asthma and COPD)

bet9 announces an investment led by Fidelity Growth Partners India into the newly launched Consumer Healthcare business

bet9 Board Announces Appointment of Samina Vaziralli onto the Board of Directors

Stempeutics receives Japan process patent for its novel stem cell drug “Stempeucel®”

bet9 Announces US FDA Approval for the World’s First Paediatric Lopinavir and ritonavir Oral Pellets for the Treatment of AIDS in Infants and Young Children

Stempeutics receives Orphan Drug Designation (ODD) in the European Union for its novel stem cell drug “Stempeucel®” for the treatment of Thromboangiitis Obliterans

Subscribe to